Benefit-Risk Analysis important for Manipulations

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
引用
收藏
页码:153 / 153
页数:1
相关论文
共 50 条
  • [1] A RADIATION BENEFIT-RISK ANALYSIS OF MAMMOGRAPHY
    JAYARAMAN, S
    AGARWAL, SK
    READ, M
    BHADURI, D
    MEDICAL PHYSICS, 1981, 8 (04) : 575 - 575
  • [2] To transplant or not: Benefit-risk analysis.
    Djulbegovic, B
    Hozo, I
    Greenwich, M
    Hozo, S
    BLOOD, 2000, 96 (11) : 436A - 437A
  • [3] Implementing Benefit-Risk Assessment for the Periodic Benefit-Risk Evaluation Report
    Warner, Margaret R.
    Wolka, Anne M.
    Noel, Rebecca A.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (03) : 342 - 346
  • [4] Implementing Benefit-Risk Assessment for the Periodic Benefit-Risk Evaluation Report
    Margaret R. Warner
    Anne M. Wolka
    Rebecca A. Noel
    Therapeutic Innovation & Regulatory Science, 2016, 50 : 342 - 346
  • [5] Benefit-risk analysis of hormone replacement therapy
    Leidenberger, FA
    GYNAKOLOGE, 1997, 30 (04): : 314 - 325
  • [6] Benefit-risk analysis for prescribing triphenylmethane dyes
    Nuernberg, W.
    Reimann, H.
    HAUTARZT, 2008, 59 (10): : 833 - 837
  • [7] BENEFIT-RISK RATIO
    TICE, LF
    AMERICAN JOURNAL OF PHARMACY, 1977, 149 (02): : 35 - 36
  • [8] Integration of PKPD relationships into benefit-risk analysis
    Bellanti, Francesco
    van Wijk, Rob C.
    Danhof, Meindert
    Della Pasqua, Oscar
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (05) : 979 - 991
  • [9] Is it Worth CANVASing for CREDENCE? A Benefit-risk Analysis
    Sinha, Binayak
    Ghosal, Samit
    CURRENT DIABETES REVIEWS, 2020, 16 (05) : 509 - 514
  • [10] State of the art in benefit-risk analysis: Introduction
    Verhagen, H.
    Tijhuis, M. J.
    Gunnlaugsdottir, H.
    Kalogeras, N.
    Leino, O.
    Luteijn, J. M.
    Magnusson, S. H.
    Odekerken, G.
    Pohjola, M. V.
    Tuomisto, J. T.
    Ueland, O.
    White, B. C.
    Holm, F.
    FOOD AND CHEMICAL TOXICOLOGY, 2012, 50 (01) : 2 - 4